Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Confirmation of appointment of CEO

22 Feb 2010 07:00

RNS Number : 4162H
Lupus Capital PLC
22 February 2010
 



 

 

Lupus Capital plc

("Lupus" or the "Company")

 

Confirmation of directorate change and appointment of Chief Executive Officer

 

As previously announced, Louis Eperjesi will today join Lupus as Chief Executive Officer and has been appointed a Director of the Company with immediate effect.

 

As at the date of this announcement, Mr. Eperjesi is the beneficial owner of 90,000 ordinary shares of 5 pence each in the Company, representing 0.07 per cent. of the issued ordinary share capital of the Company.

 

All other disclosures regarding Mr. Eperjesi's appointment required under Schedule 2(g) of the AIM Rules for Companies are unchanged from the previous announcement of 14 January 2010.

 

22 February 2010

 

Enquiries:

 

Collins Stewart Europe Limited

Mark Dickenson / Tom Hulme

 

Tel: +44 (0)20 7523 8350

College Hill

Mark Garraway / Gareth David

 

Tel: +44 (0)20 7457 2020

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUKRORRVAUAAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.